Reduction of the electrocardiographic QT interval
    1.
    发明授权
    Reduction of the electrocardiographic QT interval 有权
    降低心电图QT间期

    公开(公告)号:US07214659B2

    公开(公告)日:2007-05-08

    申请号:US10380301

    申请日:2001-09-12

    IPC分类号: A61K38/00

    CPC分类号: A61K38/28

    摘要: The present invention relates to the use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing the OTc interval and the use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing the risk of sudden death or ‘dead in bed’ syndrome; particularly in patients suffering from IDDM.

    摘要翻译: 本发明涉及胰岛素原C肽或其变体,衍生物或片段在制备用于减少OTc间期的药物中的用途,以及在制造中使用胰岛素原C肽或其变体,衍生物或片段 用于降低猝死或“死于床”综合征的风险的药物; 特别是患有IDDM的患者。